For best results when printing this announcement, please click on the linkbelow:
  http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20120919:nPnCL74782
 Patients from Turkey and abroad receive minimally invasive radiosurgery forcancer and other brain disorders on Elekta's most advanced radiosurgery systemISTANBUL,  Sept. 19, 2012  /PRNewswire/ -- Leksell Gamma Knife Perfexion -Elekta's most advanced Gamma Knife platform - became  Turkey's fifth  GammaKnife system, beginning clinical operation at  Group Florence Nightingale'sComprehensive Cancer Center  (Istanbul) on  May 25. The Cancer Center's Prof.Dr.  Talat Kiris  used Perfexion for the first time by treating a 15-year-oldIraqi boy with a partially resected skull base tumor.  Gamma Knife radiosurgery is a patient friendly alternative to traditional brainsurgery for illnesses such as metastatic disease, arteriovenous malformations(AVM) and meningiomas. With pinpoint accuracy, the system delivers up tothousands of low-intensity radiation beams to one or more targets in a singlesession. Perfexion provides even greater speed and ease of use than previousmodels.According to Prof. Dr. Kiris, both he and the Group's administration werestrongly committed to acquiring Perfexion for the Comprehensive Cancer Centerdue to the proven effectiveness of Gamma Knife surgery and to the addedsophistication of the Perfexion system."For years, Gamma Knife surgery has the accepted gold standard for the treatmentof many intracranial indications," Prof. Dr. Kiris observes. "In addition,compared to previous Gamma Knife models, Perfexion dramatically streamlines theradiosurgery workflow and expands the treatable volume with a new collimator.Treatment delivery to one or more tumors in a single session also is greatlyfacilitated in Perfexion, and allows treatment of a wider range of targetsfaster, more efficiently and safer than before."For me, Perfexion is a neurosurgeon's tool," he continues. "It's very easy touse and if you know brain anatomy very well, the system software helps you alot."First clinical cases successful  The first Perfexion case involving the boy from  Iraq  was unusual, he says."It was a highly vascular lesion that bled significantly during resection, so westopped the surgery, leaving part of it intact. He had radiosurgery withPerfexion and everything went perfectly. He flew back to his country the nextmorning."The second Perfexion patient came the very same day, a Bulgarian man with avestibular schwannoma, a common Gamma Knife radiosurgery indication. Thispatient also left the hospital on the day of his surgery. Since then, eightother private patients - encompassing an AVM and a metastasis, meningiomas andtrigeminal neuralgia - have undergone Perfexion radiosurgery.  "On  July 5, we treated a patient with a brain stem tumor from  Azerbaijan  andthe following week we treated two more patients, one with an AVM and one with avestibular schwannoma," he notes. "Next year, I predict we will treat increasingnumbers of patients with one or more metastases."For further information, please contact:Johan Andersson Melbi, Investor Relations Manager,  Elekta ABTel: +46 702 100 451, email:  johan.anderssonmelbi@elekta.com  Time zone: CET: Central European TimeMichelle Joiner, Director, Global Public Relations and Brand Management, Elekta Tel: +1 770-670-2447, email:  michelle.joiner@elekta.comTime zone: ET: Eastern TimeAbout ElektaElekta is a human care company pioneering significant innovations and clinicalsolutions for treating cancer and brain disorders. The company developssophisticated, state-of-the-art tools and treatment planning systems forradiation therapy, radiosurgery and brachytherapy, as well as workflow enhancingsoftware systems across the spectrum of cancer care. Stretching the boundariesof science and technology, providing intelligent and resource-efficientsolutions that offer confidence to both healthcare providers and patients,Elekta aims to improve, prolong and even save patient lives.  Today, Elekta solutions in oncology and neurosurgery are used in over 6,000hospitals worldwide. Elekta employs around 3,300 employees globally. Thecorporate headquarters is located in  Stockholm, Sweden, and the company islisted on the Nordic Exchange under the ticker EKTAb. Website:  
  www.elekta.com.
 SOURCE  Elekta